Financial statements Cavitel Bio
Balance sheet data of CAVITEL BIO
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Total assets | 1 291 664,68 | 1 939 352,23 | 12 832 374,17 |
A. Fixed assets | 0,00 | 2 500,00 | 6 357 257,85 |
B. Current assets | 1 286 664,68 | 1 931 852,23 | 6 470 116,32 |
C. Share capital contributions (basic funds) | 5 000,00 | 5 000,00 | 5 000,00 |
D. Own shares (stocks) | 0,00 | 0,00 | - |
Total liabilities | 1 291 664,68 | 1 939 352,23 | 12 832 374,17 |
A. Equity | -86 158,02 | -184 730,18 | -1 340 610,00 |
B. Liabilities and provisions for liabilities | 1 377 822,70 | 2 124 082,41 | 14 172 984,17 |
I. Long-term liabilities | 99 516,10 | 0,00 | 0,00 |
II. Short-term liabilities | 916 810,44 | 2 124 082,41 | 9 494 975,91 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.